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Tuoxin Cao
Daily Administration of Ibuprofen 
Modifies Neuroinflammation Gene 
Expression, but Not Neuroplasticity 
Gene Expression in Traumatic 
Brain Injured Rats
Introduction
 Each year there are at least 1.4 million civilian traumatic 
brain injury (TBI) incidents, with most as a result of a moderate 
level of injury and being treated in the emergency department 
(Langlois and Sattin 2005). The post-traumatic morbidity is 
likely to result from secondary molecular, biochemical and 
cellular events that cause additional neuronal, glial and vascular 
injuries across multiple brain areas (Thompson, Gibson et al., 
2006; Farkas and Povlishock 2007). 
 One of the primary histopathological consequences 
associated with TBI is microglial activation and ensuing 
neuroinflammation(Csuka, Hans et al. 2000). Inflammation 
in neurodegenerative conditions can be both detrimental and 
beneficial(Gensel, Nakamura et al. 2009). Inflammation can 
clear dead or dying tissue. On the other hand, previous studies 
in spinal cord injury and Alzheimer diseases have shown that 
microglia activation, especially the alternative activation of 
microglia, can be one factor that promotes neuroplasticity 
and potentially affect the recovery of the patient (Donnelly 
and Popovich, 2008; Popovich and Longbrake, 2008; Colton, 
2009; Colton and Wilcock, 2009; Gensel, Nakamura et al., 
2009; Kigerl, Gensel et al., 2009). We hypothesize that the 
primary mechanical forces of TBI initiate microglia activation, 
and therefore anti-inflammatory treatments would reduce 
microglia activation, helping to control post-traumatic 
neuroplasticity. Here, we examine the post-traumatic 
microglia activation states: classical activation associated with 
neurotoxicity, alternative activation associated with recovery, 
and acquired deactivation associated with anti-inflammatory 
response (Colton and Wilcock, 2009; Gensel, Nakamura et al., 
2009). Also, we examine the ability of the anti-inflammatory 
ibuprofen to modulate microglial activation and neuroplasticity 
gene expression using real-time PCR.
Experimental Design 
 Adult male Sprague-Dawley rats (350–375 g) were 
subjected to midline fluid percussion injury (FPI) consistent 
with methods described previously (Lifshitz, Kelley et al., 
2007; Lifshitz, 2008; Hosseini and Lifshitz, 2009; McNamara, 
Lisembee et al., 2010). A craniotomy was performed and the 
injury hub was secured on the skull of rats under isoflurane 
anesthesia. As each rat’s reflex response returned, a sham injury 
(the animal is connected to the injury device, but no injury 
treated with daily administration of either saline or ibuprofen 
(20mg/kg; i.p. injection). At 7 days post-injury, each animal 
was euthanized and tissue biopsies of the somatosensory cortex 
and thalamus were taken from the coronal brain section. 
From the tissue, the mRNA was isolated (FastPrep®-24 sample 
preparation system, M.P. Biomedicals and MagMax™ Express, 
Applied Biosystems Inc.), quantified (NanoDrop ND-1000 
spectrophotometer), and then converted to complementary 
DNA (cDNA; High Capacity RNA-to-cDNA Kit, Applied 
Biosystems Inc.). The cDNA was used as a template for 
quantitative real-time PCR using commercially-available gene 
expression assays (Taqman® Gene Expression Assay, Applied 
Biosystems). Within each animal, expression of microglia 
activation marker (TSPO), classical activation marker (CD45), 
alternative activation marker (Arg1), acquired deactivation 
marker (TGFß1) and neuro-plasticity markers (GAP43, 
Synaptophysin) were normalized to the gene expression level 
of endogenous control, 18s rRNA (Colton, 2009; Colton and 
Wilcock, 2009; Cook, Vink et al. 2009; Gensel, Nakamura 
et al., 2009; Harris, Reeves et al., 2009; Kigerl, Gensel et 
al., 2009). Gene expression in each group was averaged and 
normalized to the sham-vehicle treated group using 2-ΔΔCT 
method (Livak and Schmittgen, 2001).
 Gene expression in all other groups was expressed as the 
percentage change of sham-vehicle group. Peirce’s criterion 
introduced) or a moderate (1.9-2.0 atm) FPI was introduced 
to each rat. Uninjured (n=12) and injured rats (n=16) were 
0 . 0
0 . 5
1 . 0
1 . 5
2 . 0
2 . 5
G A P 4 3 S y n a p to p hy s in
s h a m
7 d  F P I  - S a l i n e
7 d  F P I  - I b u p r o f e n
 
0 . 0
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
1 . 2
1 . 4
G A P 4 3 S y n a p to p hy s in
S h a m
7 d  F P I - v e h i c l e
7 d  F P I - i b u p r o f e n
Cortex Thalam
Figure 2: Neuroplasticity gene expression was not affected by brain 
injury or ibuprofen treatment in the cortex or thalamus (n=5-6/
group). The sham vehicle-treated and sham ibuprofen-treated 
groups were combined into a single sham group after confirming no 
significant difference between groups.
was used to identify outliers in the data sets (Ross 2003). To 
maximize statistical power, sham-saline treated and sham-
ibuprofen treated groups were combined into one sham 
group after confirming no significant differences between the 
two groups by student t-test. All statistical assessments were 
performed using one-way analysis of variance (ANOVA) 
followed by Tukey-Kramer multiple comparisons test using 
GraphPad InStat statistical software. Results are considered 
significant if p < 0.05. All data are presented as mean ± 
standard error of the mean (SEM).
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Figure 1:Post-traumatic inflammatory gene expression after 
anti-inflammatory treatment. 7 days after fluid percussion 
injury (FPI) are compared between sham, injured-saline 
treated, and injured-ibuprofen treated rats (n= 5-6 per 
group). In the cortex, gene expression of both TSPO and 
TGFB1 increased after ibuprofen treatment compared to 
sham. Injury-induced increases in CD45 gene expression at 
7 days post-FPI was not affected by ibuprofen treatment. 
In the thalamus, gene expression indicates significantly 
increased classical (TSPO and CD45) and anti-inflammatory 
(TGFB1) microglial activation at 7 days post-FPI. Ibuprofen 
treatment reduced gene expression levels TSPO, CD45 and 
TGFB1 such that they are no longer significantly different 
from sham. *, p < 0.05; **, p < 0.01 compared to sham.
 TSPO: translocator protein 18 kDa
CD45: protein tyrosine phosphatase receptor type C
TGFßI: transforming growth factor ß1
Result
 Gene expression in the two brain regions responded 
differently to anti-inflammation treatment. In the cortex, 
daily ibuprofen administration was ineffective in attenuating 
the injury-induced increase in classical microglia activation 
and acquired microglia deactivation (Figure 1). TSPO gene 
expression remained significantly elevated above sham in the 
ibuprofen-treated brain-injured animals (F(2,15) = 5.123; p 
= 0.0201).TGFß1 gene expression was increased significantly 
in injured ibuprofen-treated animals compared to sham 
animals (F(2,12) = 6.749; p = 0.0109), suggesting increased 
anti-inflammatory gene expression following ibuprofen 
administration. Injury-induced increases in CD45 gene 
expression at 7 days post-FPI was not significantly affected by 
ibuprofen treatment, whereas ibuprofen treatment increased 
TSPO and TGFß1 gene expression.
 In VPM, the fourfold significant increase in TSPO gene 
expression in brain-injured saline-treated animals was down-
regulated by the ibuprofen administration to the level where 
no significant change was found compared to the sham group 
(F(2,14) = 6.754; p = 0.0088). Similar results were obtained 
for the gene expression of CD45 (F(2,13) = 8.160; p = 
0.0051) and TGFß1 (F(2,12) = 4.844; p = 0.0287); the gene 
expression increased significantly with saline treatment, while 
administration of ibuprofen down-regulated gene expression. 
As found previously, arginase 1 gene expression was not 
significantly different between sham animals, FPI-injured 
animals and FPI-injured ibuprofen-treated animals (S1BF: 
F(2,14) = 0.4881, p = 0.6239; VPM: F(2,14) = 0.6358, p = 
0.5441)
 Even though anti-inflammatory treatment resulted in 
various changes in both classical activation and acquired 
deactivation in cortex and thalamus, no significant change in 
neuroplasticity gene expression was observed in either brain 
region as the result of ibuprofen administration (Figure 2). 
Classical and acquired activation of microglia may not be 
directly associated with neuroplasticity gene expression.
Discussion
 Results of TSPO gene expression suggest there is 
increased microglia activation in the cortex and reduced 
microglial activation in the thalamus when ibuprofen is 
administered. In the cortex, increased TGFß1 gene expression 
occurs concomitantly with an increase in TSPO gene 
expression, suggesting interplay between inflammatory and 
anti-inflammatory responses. Also the ibuprofen treatment 
did not affect the CD45 gene expression significantly in the 
cortex. The result suggests ibuprofen treatment is not able to 
reduce classical activation of microglia in the cortex, and thus 
neurotoxic effect of microglia is still present. Higher doses 
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may have a positive outcome on cortical gene expression. 
On the other hand, in the thalamus, ibuprofen not only 
reduced CD45 gene expression but also reduced TGFß1 gene 
expression, suggesting reduction in both classical activation 
and acquired deactivation of microglia. Higher doses may have 
a negative effect on thalamic gene expression. The contrasting 
responses in the two brain regions to ibuprofen are unknown, 
but highlight different microenvironments in the two brain 
regions.
 Only the arginase 1 gene expression did not change as 
the result of the FPI or ibuprofen treatment, indicating that 
arginase 1 gene expression is not affected by traumatic brain 
injury at 7 days time point and it is independent of the COX2 
pathway. An experiment in spinal cord injury has shown that 
there is an increase in arginase 1 gene expression at 1 and 3 
days (Kigerl, Gensel et al. 2009), which may hold true for 
TBI. By 7 days post-injury, arginase 1 gene expression might 
have already subsided. We have found, however, the alternative 
activation is not likely to be present at 7 days post-injury and 
the alternative activation process seems to be independent of 
COX2 pathways. 
 TGFß1 can reduce expression of TNFß, IL1ß and other 
proinflammatory cytokines. From this and previous studies, 
TGFß1 gene expression has correlated well with TSPO 
and CD45 gene expression . This result suggests that the 
expression of TGFß1 might be a compensatory mechanism to 
reduce classical activation process. In each experiment, gene 
expression of TGFß1 is shown to increase as CD45 and TSPO 
gene expression increases and vice versa. 
 Whether increased or decreased, ibuprofen was successful 
in modulating inflammation-related gene expression in 
FPI-injured rats. Despite the changes in the inflammation 
gene expression, neuroplasticity genes were not modulated 
by ibuprofen administration. Lack of neuroplasticity 
gene expression change is possibly correlated with lack of 
alternative activation of microglia (Gensel, Nakamura et 
al., 2009; Kigerl, Gensel et al., 2009). The result might be 
different if neuroplasticity gene expression is measured earlier. 
In conclusion, at this point we have not found a relationship 
between neuroplasticity gene expression and microglia 
activation process. These experiments will be followed-up on by 
comparing changes of microglia activation and neuroplasticity 
protein quantity in ibuprofen-treated and ibuprofen-non-
treated animals.
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